U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Partial nephrogenic diabetes insipidus

MedGen UID:
836392
•Concept ID:
C3875046
•
Disease or Syndrome
SNOMED CT: Partial nephrogenic diabetes insipidus (368961000119107)

Professional guidelines

PubMed

Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder.
Turan T, Eşel E, Tokgöz B, Aslan S, Sofuoğlu S, Utaş C, Keleştimur F
Prog Neuropsychopharmacol Biol Psychiatry 2002 Apr;26(3):561-5. doi: 10.1016/s0278-5846(01)00308-6. PMID: 11999908
Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
Jakobsson B, Berg U
Acta Paediatr 1994 May;83(5):522-5. doi: 10.1111/j.1651-2227.1994.tb13072.x. PMID: 8086732

Recent clinical studies

Etiology

Partial nephrogenic diabetes insipidus associated with lithium therapy.
Nandoshvili E, Hyer S, Johri N
BMJ Case Rep 2019 Sep 6;12(9) doi: 10.1136/bcr-2019-231093. PMID: 31494590Free PMC Article
Impairment of AVP regulation in 17alpha-hydroxylase deficiency, a unique form of adrenal insufficiency.
Leal AM, Elias PC, Moreira AC
J Endocrinol Invest 2002 Jul-Aug;25(7):635-8. doi: 10.1007/BF03345089. PMID: 12150340
Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder.
Turan T, Eşel E, Tokgöz B, Aslan S, Sofuoğlu S, Utaş C, Keleştimur F
Prog Neuropsychopharmacol Biol Psychiatry 2002 Apr;26(3):561-5. doi: 10.1016/s0278-5846(01)00308-6. PMID: 11999908
Lithium-induced nephrogenic diabetes insipidus in older people.
Mukhopadhyay D, Gokulkrishnan L, Mohanaruban K
Age Ageing 2001 Jul;30(4):347-50. doi: 10.1093/ageing/30.4.347. PMID: 11509315

Diagnosis

Partial Nephrogenic Diabetes Insipidus in a Burned Patient Receiving Sevoflurane Sedation With an Anesthetic Conserving Device-A Case Report.
Muyldermans M, Jennes S, Morrison S, Soete O, François PM, Keersebilck E, Rose T, Pantet O
Crit Care Med 2016 Dec;44(12):e1246-e1250. doi: 10.1097/CCM.0000000000001956. PMID: 27414478
Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family.
Yamashita S, Hata A, Usui T, Oda H, Hijikata A, Shirai T, Kaneko N, Hata D
J Pediatr Endocrinol Metab 2016 May 1;29(5):591-6. doi: 10.1515/jpem-2015-0323. PMID: 26974133
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, Phylactou LA
Metabolism 2012 Jul;61(7):922-30. Epub 2012 Mar 3 doi: 10.1016/j.metabol.2012.01.005. PMID: 22386940
V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T
J Biol Chem 2012 Jan 13;287(3):2099-106. Epub 2011 Dec 5 doi: 10.1074/jbc.M111.268797. PMID: 22144672Free PMC Article
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S
Clin Endocrinol (Oxf) 2008 Mar;68(3):395-403. Epub 2007 Oct 17 doi: 10.1111/j.1365-2265.2007.03054.x. PMID: 17941907

Therapy

Bendamustine-induced nephrogenic diabetes insipidus - A case report.
Desjardins A, Le-Nguyen V, Turgeon-Mallette L, Vo C, Boudreault JS, Rioux JP, Feng X, Veilleux A
J Oncol Pharm Pract 2022 Jan;28(1):205-210. Epub 2021 May 14 doi: 10.1177/10781552211013878. PMID: 33990157Free PMC Article
Partial nephrogenic diabetes insipidus associated with lithium therapy.
Nandoshvili E, Hyer S, Johri N
BMJ Case Rep 2019 Sep 6;12(9) doi: 10.1136/bcr-2019-231093. PMID: 31494590Free PMC Article
Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
Uwumugambi NA, Sanchorawala V, Shelton AC, Stern L, Gordon CE
Am J Kidney Dis 2017 Feb;69(2):317-319. Epub 2016 Oct 22 doi: 10.1053/j.ajkd.2016.07.037. PMID: 27780577
Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ
Clin J Am Soc Nephrol 2008 Sep;3(5):1324-31. Epub 2008 Jul 2 doi: 10.2215/CJN.01640408. PMID: 18596116Free PMC Article
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S
Clin Endocrinol (Oxf) 2008 Mar;68(3):395-403. Epub 2007 Oct 17 doi: 10.1111/j.1365-2265.2007.03054.x. PMID: 17941907

Prognosis

Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family.
Yamashita S, Hata A, Usui T, Oda H, Hijikata A, Shirai T, Kaneko N, Hata D
J Pediatr Endocrinol Metab 2016 May 1;29(5):591-6. doi: 10.1515/jpem-2015-0323. PMID: 26974133
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
Schernthaner-Reiter MH, Adams D, Trivellin G, Ramnitz MS, Raygada M, Golas G, Faucz FR, Nilsson O, Nella AA, Dileepan K, Lodish M, Lee P, Tifft C, Markello T, Gahl W, Stratakis CA
Eur J Pediatr 2016 May;175(5):727-33. Epub 2016 Jan 21 doi: 10.1007/s00431-015-2684-4. PMID: 26795631Free PMC Article
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S
Clin Endocrinol (Oxf) 2008 Mar;68(3):395-403. Epub 2007 Oct 17 doi: 10.1111/j.1365-2265.2007.03054.x. PMID: 17941907

Clinical prediction guides

Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene.
Drosataki E, Maragkou S, Dermitzaki K, Stavrakaki I, Lygerou D, Latsoudis H, Pleros C, Petrakis I, Zaganas I, Stylianou K
BMC Nephrol 2022 May 12;23(1):182. doi: 10.1186/s12882-022-02812-9. PMID: 35549682Free PMC Article
Partial Nephrogenic Diabetes Insipidus in a Burned Patient Receiving Sevoflurane Sedation With an Anesthetic Conserving Device-A Case Report.
Muyldermans M, Jennes S, Morrison S, Soete O, François PM, Keersebilck E, Rose T, Pantet O
Crit Care Med 2016 Dec;44(12):e1246-e1250. doi: 10.1097/CCM.0000000000001956. PMID: 27414478
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
Schernthaner-Reiter MH, Adams D, Trivellin G, Ramnitz MS, Raygada M, Golas G, Faucz FR, Nilsson O, Nella AA, Dileepan K, Lodish M, Lee P, Tifft C, Markello T, Gahl W, Stratakis CA
Eur J Pediatr 2016 May;175(5):727-33. Epub 2016 Jan 21 doi: 10.1007/s00431-015-2684-4. PMID: 26795631Free PMC Article
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S
Clin Endocrinol (Oxf) 2008 Mar;68(3):395-403. Epub 2007 Oct 17 doi: 10.1111/j.1365-2265.2007.03054.x. PMID: 17941907
Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M
Mol Endocrinol 1997 Nov;11(12):1806-13. doi: 10.1210/mend.11.12.0017. PMID: 9369448

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...